Lixte Biotechnology Holdings's market cap is currently ―. The company's EPS TTM is $-2.772; its P/E ratio is -1.18; Lixte Biotechnology Holdings is scheduled to report earnings on April 27, 2018, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	-	-	-	-	$ 0.00
Gross Profit	-	-	$ 519.48K	$ 1.34M	-
EBIT	$ -1.02M	$ -1.67M	$ 1.38M	$ -1.63M	$ -1.48M
EBITDA	$ -1.02M	$ -1.67M	$ 1.38M	$ -1.63M	$ -1.48M
Net Income Common Stockholders	$ -1.03M	$ -1.67M	$ 1.37M	$ -1.63M	$ -1.48M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 4.20M	$ 2.91M	$ 4.09M	$ 5.35M	$ 6.56M
Total Assets	$ 4.31M	$ 3.10M	$ 4.33M	$ 5.56M	$ 6.82M
Total Debt	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Net Debt	$ -4.20M	$ -2.91M	$ -4.09M	$ -5.35M	$ -6.56M
Total Liabilities	$ 313.86K	$ 402.61K	$ 223.63K	$ 394.79K	$ 408.33K
Stockholders Equity	$ 3.99M	$ 2.69M	$ 4.08M	$ 5.17M	$ 6.41M
Cash Flow	-
Free Cash Flow	$ -902.12K	$ -1.18M	$ -1.27M	$ -1.21M	$ -1.17M
Operating Cash Flow	$ -902.12K	$ -1.18M	$ -1.27M	$ -1.21M	$ -1.17M
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	-	-	$ 6.28K	-	$ 0.00

Currency in USD

Lixte Biotechnology Holdings Earnings and Revenue History

Income Statement >

Lixte Biotechnology Holdings Debt to Assets

Balance Sheet >

Lixte Biotechnology Holdings Cash Flow

Cash Flow >

Lixte Biotechnology Holdings Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing